MGTA-456 Earns FDA’s Regenerative Medicine Advanced Therapy Designation
MGTA-456 Earns FDA’s Regenerative Medicine Advanced Therapy Designation Source Reference The...
Read MoreMGTA-456 Earns FDA’s Regenerative Medicine Advanced Therapy Designation Source Reference The...
Read MoreEngineered killer T cells could provide long-lasting immunity against cancer Source Reference...
Read MoreLineage Cell Therapeutics Announces Issuance of U.S. Patent for Method of Treating Spinal Cord...
Read MoreMesenchymal stem cells for cartilage regeneration in osteoarthritis Source Reference New life...
Read MoreNew facility brings the most advanced cellular therapies to patients Source Reference Stem cell...
Read More